867160-71-2
867160-71-2
Chemical Structure
Linsitinib
Synonym(s): OSI-906
- CAS No.: 867160-71-2
- Formula:C26H23N5O
- Molecular Weight:421.49
IUPAC Name: (1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol
InChIKey: PKCDDUHJAFVJJB-VLZXCDOPSA-N
SMILES: O[C@@]1(C)C[C@@H](C2=NC(C3=CC=C4C=CC(C5=CC=CC=C5)=NC4=C3)=C6C(N)=NC=CN62)C1
Biological Activity: Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Linsitinib | 99.90% | Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Linsitinib (Standard) | 99.66% | Linsitinib (Standard) is the analytical standard of Linsitinib. This product is intended for research and analytical applications. Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.70
HY-160635Ack1 inhibitor 2 -
Similarity Score 0.59
HY-147580BTK-IN-10 -
Similarity Score 0.57
HY-124646KIRA-7 -
Similarity Score 0.57
HY-160168BTK-IN-31 -
Similarity Score 0.54
HY-169307BTK-IN-38 -
Similarity Score 0.54
HY-111065OXA-01 -
Similarity Score 0.53
HY-147582BTK-IN-12 -
Similarity Score 0.53
HY-19708KIRA6 -
Similarity Score 0.52
HY-18509IRE1α kinase-IN-2 -
Explore the MedChemAI to find more analogs
